Introduction Amyloid-β (Aβ) and tau accumulations may occur independently and
concurrently as exemplified by primary age-related tauopathy and Alzheimer's disease (AD), …

Background We recently developed a positron emission tomography (PET) probe, [ 18 F]PM‐PBB3,
to detect tau lesions in diverse tauopathies, including mixed three‐repeat and four‐…

Background [ 11 C]pyridinyl‐butadienyl‐benzothiazole 3 is a PET imaging agent designed
for capturing pathological tau aggregates in diverse neurodegenerative disorders, and would …

Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by glial
cytoplasmic inclusions (GCIs) 1 composed of α-synuclein aggregates as neuropathological …

Objective Apathy is a common neuropsychological symptom in Alzheimer’s disease (AD),
and previous studies demonstrated that neuronal loss and network disruption in some brain …

Patients with progressive supranuclear palsy (PSP) frequently exhibit apathy but the
neuropathological processes leading to this phenotype remain elusive. We aimed to examine the …

Objective Increasing evidence suggests that reactive astrocytes are associated with Alzheimer's
disease (AD). However, its underlying pathogenesis remains unknown. Given the role of …

Positron emission tomography (PET) with 18 F-PM-PBB3 ( 18 F-APN-1607, 18 F-Florzolotau)
enables high-contrast detection of tau depositions in various neurodegenerative dementias…

Introduction Corticobasal degeneration (CBD) is the most common neuropathological substrate
for clinically diagnosed corticobasal syndrome (CBS), while identifying CBD pathology …

Objective To characterize the distribution of tau pathology in patients with amyotrophic lateral
sclerosis/parkinsonism dementia complex on the Kii Peninsula (Kii ALS/PDC) by tau PET …